| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $195.7M | — | +9.1% |
| Cost of Revenue | $87.1M | — | +7.0% |
| Gross Profit | $108.6M | — | +10.9% |
| R&D Expense | $31.3M | — | +6.1% |
| SG&A Expense | $33.3M | — | +23.8% |
| Operating Income | -$25.3M | — | -75.7% |
| Pre-tax Income | -$19.1M | — | -203.2% |
| Income Tax | $1.4M | — | -6.7% |
| Net Income | -$20.5M | — | -162.8% |
| EPS (Basic) | -$0.12 | — | -140.0% |
| EPS (Diluted) | -$0.12 | — | -140.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $789.8M | -0.4% | +5.6% |
| Accounts Receivable | $60.0M | -8.3% | +0.2% |
| Current Assets | $893.4M | -0.5% | +4.6% |
| Total Assets | $1.00B | +0.1% | +5.2% |
| Current Liabilities | $362.4M | +1.3% | +8.3% |
| Total Liabilities | $368.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $14.6M | — | -56.4% |
| Investing Cash Flow | -$11.6M | — | -41.5% |
| Financing Cash Flow | -$5.7M | — | -14.0% |
| +8.2% |
| Stockholders' Equity | $631.8M | -0.6% | +3.5% |